Eli Lilly (LLY) Net Cash Flow (2009 - 2026)

Eli Lilly has reported Net Cash Flow for 18 years, with the latest figure at -$2.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 568.73% year-over-year to -$2.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 147.01% YoY), and the FY2025 full-year result was $3.6 billion, up 386.33% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$2.1 billion, up from -$2.5 billion in the prior quarter.
• The five-year high for Net Cash Flow was $6.4 billion in Q3 2025, with the low at -$2.5 billion in Q4 2025.
• Historically, Net Cash Flow has averaged $77.7 million across 5 years, with a median of -$81.5 million in 2024.
• Annual changes were most pronounced in 2023 — Net Cash Flow plunged 16689.47% — and 2025, when it surged 7933.5%.
• Eli Lilly's Net Cash Flow stood at -$422.2 million in 2022, then soared by 173.07% to $308.5 million in 2023, then climbed by 6.13% to $327.4 million in 2024, then slumped by 850.27% to -$2.5 billion in 2025, then increased by 16.42% to -$2.1 billion in 2026.
• The last three Net Cash Flow figures came in at -$2.1 billion (Q1 2026), -$2.5 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.